Skip to main content
. 2023 May 24;8(7):640–649. doi: 10.1001/jamacardio.2023.1090

Figure 2. Comparison of Empagliflozin vs Placebo on Kansas City Cardiomyopathy Questionnaire Subdomain Scores According to Baseline Diuretic Therapy.

Figure 2.

KCCQ-CSS indicates Kansas City Cardiomyopathy Questionnaire clinical summary score.